PSMA PET/MR radiomics to improve postsurgical Gleason score prediction in prostate cancer

Autor: Solari, EL, Gafita, A, Schachoff, S, Visvikis, D, Weber, W, Eiber, M, Hatt, M, Nekolla, SG

Publikováno v: Nuklearmedizin. Nuclear medicine; April 2021, Vol. 60 Issue: 2

Value of PET ECG gating in a cross-validation study of cardiac function assessment by PET/MR imaging.

Autor: Villagran Asiares A; Nuklearmedizinische Klinik und Poliklinik, Klinikum Rechts der Isar, School of Medicine, Technical University of Munich, Munich, Germany. alberto.villagran@tum.de., Vitadello T; Klinik und Poliklinik für Innere Medizin I, Klinikum Rechts der Isar, School of Medicine, Technical University of Munich, Munich, Germany., Bogdanovic B; Nuklearmedizinische Klinik und Poliklinik, Klinikum Rechts der Isar, School of Medicine, Technical University of Munich, Munich, Germany., Solari EL; Nuklearmedizinische Klinik und Poliklinik, Klinikum Rechts der Isar, School of Medicine, Technical University of Munich, Munich, Germany., McIntosh L; Department of Physical Sciences, Peter MacCallum Cancer Centre, Melbourne, Australia., Schachoff S; Nuklearmedizinische Klinik und Poliklinik, Klinikum Rechts der Isar, School of Medicine, Technical University of Munich, Munich, Germany., Ibrahim T; Klinik und Poliklinik für Innere Medizin I, Klinikum Rechts der Isar, School of Medicine, Technical University of Munich, Munich, Germany., Nekolla SG; Nuklearmedizinische Klinik und Poliklinik, Klinikum Rechts der Isar, School of Medicine, Technical University of Munich, Munich, Germany.; DZHK (German Centre for Cardiovascular Research), Partner site Munich Heart Alliance, Munich, Germany.

Publikováno v: Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology [J Nucl Cardiol] 2023 Jun; Vol. 30 (3), pp. 1050-1060. Date of Electronic Publication: 2022 Sep 30.

PET/MR Technology: Advancement and Challenges.

Autor: Bogdanovic B; Department of Nuclear Medicine, Klinikum rechts der Isar, Technische Universität München, Munich, Germany., Solari EL; Department of Nuclear Medicine, Klinikum rechts der Isar, Technische Universität München, Munich, Germany., Villagran Asiares A; Department of Nuclear Medicine, Klinikum rechts der Isar, Technische Universität München, Munich, Germany., McIntosh L; Department of Physical Sciences, Peter MacCallum Cancer Centre, Melbourne, Australia., van Marwick S; Department of Nuclear Medicine, Klinikum rechts der Isar, Technische Universität München, Munich, Germany., Schachoff S; Department of Nuclear Medicine, Klinikum rechts der Isar, Technische Universität München, Munich, Germany., Nekolla SG; Department of Nuclear Medicine, Klinikum rechts der Isar, Technische Universität München, Munich, Germany; DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany. Electronic address: stephan.nekolla@tum.de.

Publikováno v: Seminars in nuclear medicine [Semin Nucl Med] 2022 May; Vol. 52 (3), pp. 340-355. Date of Electronic Publication: 2021 Dec 28.

The added value of PSMA PET/MR radiomics for prostate cancer staging.

Autor: Solari EL; School of Medicine, Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University Munich, Munich, Germany. elucas.solari@tum.de., Gafita A; School of Medicine, Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University Munich, Munich, Germany., Schachoff S; School of Medicine, Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University Munich, Munich, Germany., Bogdanović B; School of Medicine, Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University Munich, Munich, Germany., Villagrán Asiares A; School of Medicine, Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University Munich, Munich, Germany., Amiel T; School of Medicine, Department of Urology, Klinikum rechts der Isar, Technical University Munich, Munich, Germany., Hui W; School of Medicine, Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University Munich, Munich, Germany., Rauscher I; School of Medicine, Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University Munich, Munich, Germany., Visvikis D; INSERM, UMR 1101, LaTIM, Univ Brest, Brest, France., Maurer T; Department of Urology and Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany., Schwamborn K; School of Medicine, Institute of Pathology, Klinikum rechts der Isar, Technical University Munich, Munich, Germany., Mustafa M; School of Medicine, Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University Munich, Munich, Germany., Weber W; School of Medicine, Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University Munich, Munich, Germany., Navab N; School of Computer Science, Computer Aided Medical Procedures and Augmented Reality, Technical University Munich, Munich, Germany., Eiber M; School of Medicine, Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University Munich, Munich, Germany., Hatt M; INSERM, UMR 1101, LaTIM, Univ Brest, Brest, France., Nekolla SG; School of Medicine, Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.

Publikováno v: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2022 Jan; Vol. 49 (2), pp. 527-538. Date of Electronic Publication: 2021 Jul 13.